However, a number of studies using PPARα k.o. mice have shown that the anti-inflammatory effects of 16:1n-7 in models of NAFLD and NASH do not occur downstream of PPARα activation [102,103,104]. This evidence concerns the gene PPARA and metabolic dysfunction-associated steatotic liver disease.